MTFB - Motif Bio Plc Stock Price, News & Analysis

$8.60 -0.39 (-4.34 %)
(As of 11/24/2017 09:25 AM ET)
Previous Close$8.99
Today's Range$8.60 - $8.70
52-Week Range$5.25 - $13.75
Volume800 shs
Average Volume5,181 shs
Market Capitalization$1.69 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Motif Bio Plc (NASDAQ:MTFB)

Motif Bio Plc logo


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MTFB
CUSIPN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio0.98%
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$1.00 per share
Price / Book8.60

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees6
Outstanding Shares196,210,000

Frequently Asked Questions for Motif Bio Plc (NASDAQ:MTFB)

What is Motif Bio Plc's stock symbol?

Motif Bio Plc trades on the NASDAQ under the ticker symbol "MTFB."

Where is Motif Bio Plc's stock going? Where will Motif Bio Plc's stock price be in 2017?

2 Wall Street analysts have issued 1-year target prices for Motif Bio Plc's stock. Their forecasts range from $25.00 to $32.00. On average, they anticipate Motif Bio Plc's stock price to reach $28.50 in the next year. View Analyst Ratings for Motif Bio Plc.

Who are some of Motif Bio Plc's key competitors?

When did Motif Bio Plc IPO?

(MTFB) raised $17 million in an IPO on Friday, November 18th 2016. The company issued 2,400,000 shares at a price of $6.98 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

How do I buy Motif Bio Plc stock?

Shares of Motif Bio Plc can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Motif Bio Plc's stock price today?

One share of Motif Bio Plc stock can currently be purchased for approximately $8.60.

How big of a company is Motif Bio Plc?

Motif Bio Plc has a market capitalization of $1.69 billion. Motif Bio Plc employs 6 workers across the globe.

How can I contact Motif Bio Plc?

Motif Bio Plc's mailing address is 125 Park Avenue 25th Floor, New York NY, 10011. The company can be reached via phone at 212-210-6248 or via email at [email protected]


MarketBeat Community Rating for Motif Bio Plc (MTFB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Motif Bio Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Motif Bio Plc (NASDAQ:MTFB)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $28.50 (231.40% upside)

Consensus Price Target History for Motif Bio Plc (NASDAQ:MTFB)

Price Target History for Motif Bio Plc (NASDAQ:MTFB)

Analysts' Ratings History for Motif Bio Plc (NASDAQ:MTFB)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/11/2017HC WainwrightSet Price TargetBuy$32.00N/AView Rating Details
4/24/2017Rodman & RenshawBoost Price TargetBuy -> Buy$16.00 -> $25.00LowView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History for Motif Bio Plc (NASDAQ:MTFB)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Motif Bio Plc (NASDAQ:MTFB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.80)($0.80)($0.80)
Q3 20171($0.69)($0.69)($0.69)
Q4 20171($0.70)($0.70)($0.70)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Motif Bio Plc (NASDAQ:MTFB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Motif Bio Plc (NASDAQ MTFB)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Motif Bio Plc (NASDAQ MTFB)

Source:
DateHeadline
Zacks: Motif Bio Plc (MTFB) Given Consensus Rating of "Strong Buy" by BrokeragesZacks: Motif Bio Plc (MTFB) Given Consensus Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - November 19 at 11:46 PM
Motif Bio secures up to US$20 million debt financingMotif Bio secures up to US$20 million debt financing
finance.yahoo.com - November 15 at 6:33 AM
 Motif Bio Plc (MTFB) Given $31.50 Average Target Price by Analysts Motif Bio Plc (MTFB) Given $31.50 Average Target Price by Analysts
www.americanbankingnews.com - November 3 at 2:00 PM
MTFB. Motif Bio Plc-MTFB. Motif Bio Plc-
www.lse.co.uk - October 15 at 7:48 PM
Should You Buy Motif Bio plc (AIM:MTFB) Now?Should You Buy Motif Bio plc (AIM:MTFB) Now?
finance.yahoo.com - October 13 at 7:05 AM
Motif Bio Plc (MTFB) Rating Reiterated by HC WainwrightMotif Bio Plc (MTFB) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - October 11 at 8:02 AM
MTFB: Positive Results From Second Phase 3 Study of Iclaprim; NDA Filing Anticipated in 1Q18MTFB: Positive Results From Second Phase 3 Study of Iclaprim; NDA Filing Anticipated in 1Q18
finance.yahoo.com - October 6 at 9:32 AM
HC Wainwright Raises Motif Bio Plc (MTFB) Price Target to $32.00HC Wainwright Raises Motif Bio Plc (MTFB) Price Target to $32.00
www.americanbankingnews.com - October 4 at 9:32 AM
Motif Bio reports half-year 2017 financial results and operational progressMotif Bio reports half-year 2017 financial results and operational progress
www.nasdaq.com - September 29 at 1:20 PM
Motif Bio Plcs (MTFB) Buy Rating Reaffirmed at HC WainwrightMotif Bio Plc's (MTFB) Buy Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - September 20 at 9:42 AM
Motif Bio announces iclaprim granted Orphan Drug Designation by US FDA for treatment of Staphylococcus aureus lung infections in patients with cystic fibrosisMotif Bio announces iclaprim granted Orphan Drug Designation by US FDA for treatment of Staphylococcus aureus lung infections in patients with cystic fibrosis
finance.yahoo.com - September 16 at 6:41 AM
Motif Bio to Host Investor and Analyst Event on September 20, 2017 in New YorkMotif Bio to Host Investor and Analyst Event on September 20, 2017 in New York
finance.yahoo.com - September 9 at 6:25 AM
Motif Bio Plc (MTFB) Forecasted to Post Q2 2017 Earnings of ($0.80) Per ShareMotif Bio Plc (MTFB) Forecasted to Post Q2 2017 Earnings of ($0.80) Per Share
www.americanbankingnews.com - September 8 at 5:40 AM
MTFB: Initiating Coverage of Motif Bio Plc; Novel Antibiotic With Positive Phase 3 ResultsMTFB: Initiating Coverage of Motif Bio Plc; Novel Antibiotic With Positive Phase 3 Results
finance.yahoo.com - September 6 at 6:34 AM
Motif Bio to present at upcoming investor and scientific conferencesMotif Bio to present at upcoming investor and scientific conferences
finance.yahoo.com - September 1 at 6:06 AM
Motif Bio to Present at the 7th Annual Trout Group Hamptons CEO Roundtable Conference on August 17thMotif Bio to Present at the 7th Annual Trout Group Hamptons CEO Roundtable Conference on August 17th
finance.yahoo.com - August 15 at 2:21 AM
Motif Bio’s second Phase 3 clinical trial in ABSSSI finishes patient treatment phaseMotif Bio’s second Phase 3 clinical trial in ABSSSI finishes patient treatment phase
finance.yahoo.com - August 10 at 6:03 AM
Motif Bio to Present Three Posters at IDWeek 2017Motif Bio to Present Three Posters at IDWeek 2017
finance.yahoo.com - July 7 at 7:36 AM
Motif BioSciences Inc.: Motif Bio Reports Year-End 2016 Financial ResultsMotif BioSciences Inc.: Motif Bio Reports Year-End 2016 Financial Results
www.finanznachrichten.de - May 1 at 5:38 PM
European ADRs Fractionally Lower as Financial Stocks See Mixed FortunesEuropean ADRs Fractionally Lower as Financial Stocks See Mixed Fortunes
www.nasdaq.com - April 27 at 7:12 PM

Social Media

Financials

Financials are not available for this stock.

Chart

Motif Bio Plc (NASDAQ MTFB) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.